Summary
Updated Aug 31, 2026
Pete O'Heeron is CHIEF EXECUTIVE OFFICER, Director of FibroBiologics, Inc. (FBLG). 7 SEC Form 4 filings on record going back to 2024, most recently on 4 May 2026. Most recent open-market trade: bought $6K of FBLG on 4 March 2026. Lifetime open-market purchases: $375K. Historical track record: 1/5 stars across 5 tracked purchases.
Recent Transactions
6Every recent SEC Form 4 transaction Pete O'Heeron has reported, most recent first.
Track Record
InsiderAlpha computes a forward-return-based score for every insider with enough Form 4 purchase history. The metrics below reflect realized performance after each tracked open-market purchase.
| Metric | Value |
|---|---|
| InsiderAlpha rating | ★☆☆☆☆ (1/5) |
| Total purchases tracked | 5 |
| Purchases with forward-return data | 5 |
| 30-day win rate | 0% |
| 90-day win rate | 0% |
| Avg 5-day return | +0.95% |
| Avg 30-day return | -52.20% |
| Avg 90-day return | -55.18% |
| Best 30-day return | -6.40% |
Trading Pattern
InsiderAlpha's records for Pete O'Heeron go back to 2024: 7 primary Form 4 filings, an average of 2.3 per year. The typical open-market purchase is $75K (5 buys totaling $375K). The largest single buy on record is $237K of LBSR in 2025. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Pete O'Heeron files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Ruben A. Garcia - $61K of FBLG open-market activity in the last 12 months
- Jason Davis - $29K of FBLG open-market activity in the last 12 months
- Hamid Khoja - $11K of FBLG open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Pete O'Heeron?
Pete O'Heeron is a corporate insider, tracked as CHIEF EXECUTIVE OFFICER, Director of FibroBiologics, Inc. (FBLG). InsiderAlpha holds 7 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Pete O'Heeron last file a Form 4?
The most recent primary Form 4 on record is dated 4 May 2026, one of 7 filings going back to 2024.
Has Pete O'Heeron been buying or selling stock?
Recorded transactions: 5 open-market purchases ($375K) and 0 open-market sales across all tracked filings.
How accurate is Pete O'Heeron's historical track record?
Across 5 tracked purchases, Pete O'Heeron averaged -52.2% avg 30-day return with a 0% 30-day win rate. InsiderAlpha rates the track record at 1/5 stars.
Where can I see all of Pete O'Heeron's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Pete O'Heeron and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial